Latest Breaking News On - Cancer genetics company profile - Page 1 : comparemela.com

StockNews com Begins Coverage on Cancer Genetics (NASDAQ:CGIX)

StockNews com Begins Coverage on Cancer Genetics (NASDAQ:CGIX)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Cancer genetics company profileVyant bio incCancer geneticsFree reportGet free reportRett syndromeCancer genetics daily

StockNews com Initiates Coverage on Cancer Genetics (NASDAQ:CGIX)

StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. Cancer Genetics Stock Performance CGIX stock opened at $0.18 on Tuesday. The business’s 50-day moving average price is $0.26. The company has a market […]

Vyant bio incCancer genetics company profileCancer geneticsFree reportGet free reportRett syndromeCancer genetics dailyNasdaq cgixHealth care and social assistanceInitiated coverageStocknews com

Cancer Genetics (NASDAQ:CGIX) Now Covered by StockNews com

Cancer Genetics (NASDAQ:CGIX) Now Covered by StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Vyant bio incCancer genetics company profileCancer geneticsGet free reportRett syndromeCancer genetics daily

StockNews com Begins Coverage on Cancer Genetics (NASDAQ:CGIX)

StockNews.com started coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. Cancer Genetics Price Performance Shares of CGIX opened at $0.18 on Monday. The firm has a market cap of $718,960.00, a P/E ratio of -0.09 and a […]

Vyant bio incCancer genetics company profileCancer geneticsFree reportGet free reportRett syndromeCancer genetics dailyNasdaq cgixHealth care and social assistanceInitiated coverageStocknews com

Cancer Genetics (NASDAQ:CGIX) Coverage Initiated at StockNews com

StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the stock. Cancer Genetics Price Performance NASDAQ CGIX opened at $0.18 on Friday. The stock’s fifty day moving average is $0.17. The firm has a market capitalization of $736,525.50, […]

Vyant bio incCancer genetics company profileCancer geneticsFree reportGet free reportRett syndromeCancer genetics dailyNasdaq cgixHealth care and social assistanceInitiated coverageStocknews com